Pharmaceutical Reverse Distribution

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

-

Contract Value

Not provided

Codes & Classification
Solicitation Number

19222

NAICS

-

Classification Code

-

Additional Details
Set Aside

None

Place of Performance

-

SourceSLED
Documents2
The Department of Enterprise Services (DES) of the State of Washington, in collaboration with MMCAP—a national cooperative purchasing organization managed by the Minnesota Office of State Procurement—has issued a contract opportunity for pharmaceutical reverse distribution services under State Contract No. 19222. This initiative is designed to facilitate the efficient and compliant return of unopened, expired pharmaceutical drugs from eligible government entities, including state agencies, higher education institutions, and political subdivisions. The contract encompasses both on-site and off-site reverse distribution services, ensuring flexibility to meet the diverse operational needs of participating organizations. The primary objective of this procurement is to provide a streamlined, cost-effective solution for the safe and lawful disposition of unused pharmaceuticals, thereby supporting regulatory compliance and environmental stewardship. By leveraging the MMCAP cooperative, eligible entities gain access to competitively sourced services and pricing, enhancing value and operational efficiency across the public sector healthcare landscape. To utilize this contract, organizations must first establish MMCAP membership, which involves a straightforward application process. Once membership is confirmed, agencies can set up accounts with the awarded contractor—currently PharmaLink, Inc.—and access comprehensive pricing and service options through the contractor’s online portal. Orders for reverse distribution services should reference the State Contract No. 19222 to ensure proper processing and contract compliance. Key requirements for processing pharmaceutical returns include providing a current DEA license, a current State Board of Pharmacy license, a copy of a wholesaler invoice dated within the past 90 days, the MMCAP member ID, facility contact information, and both physical and billing addresses. These documentation standards are designed to uphold regulatory requirements and ensure traceability throughout the reverse distribution process. Contract documents and further details are accessible via the MMCAP member portal, where users can search for the applicable contractor and contract category. PharmaLink, Inc. serves as the primary awarded contractor for this service, with Joe Levenson as the designated point of contact ([email protected], (954) 296-4805). This procurement adheres to RCW 39.26 and the State of Washington’s current procurement policies, with DES confirming that the contract serves the best interests of the state. The place of performance is within Washington State (State Code: WA), and the contract is open for responses until June 30, 2026. Interested parties are encouraged to review the full contract summary and documentation via the DES Contracts portal. In summary, this contract offers a robust, compliant framework for government entities in Washington State to manage pharmaceutical reverse distribution, with clear membership, documentation, and ordering procedures, and a dedicated contractor to support service delivery throughout the contract lifecycle.